CDP840: a novel inhibitor of PDE-4.
We present the in vitro characterization of a novel phosphodiesterase type 4 inhibitor, CDP840 (R-[+]-4-[2-¿3-cyclopentyloxy-4-methoxyphenyl¿-2-phenylethyl]pyridine), which has shown efficacy in a phase II allergen challenge study in asthmatics without adverse effects. CDP840 potently inhibits PDE-4...
Main Authors: | Perry, M, O'Connell, J, Walker, C, Crabbe, T, Baldock, D, Russell, A, Lumb, S, Huang, Z, Howat, D, Allen, R, Merriman, M, Walls, J, Daniel, T, Hughes, B, Laliberte, F, Higgs, G, Owens, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1998
|
Similar Items
-
The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.
by: Hughes, B, et al.
Published: (1996) -
SUPPRESSION OF ANTIGEN-INDUCED AIRWAY RESPONSES AND BRONCHIAL HYPERRESPONSIVENESS BY CDP840, A NOVEL STEREOSELECTIVE INHIBITOR OF PHOSPHODIESTERASE TYPE-IV
by: Hughes, B, et al.
Published: (1995) -
PDE 4 inhibitors: The use of molecular cloning in the design and development of novel drugs
by: Hughes, B, et al.
Published: (1997) -
Molecular cloning and expression of a human phosphodiesterase 4C.
by: Owens, R, et al.
Published: (1997) -
LZS sasar rm840j kutipan zakat
by: Mohd Zoki, Muhammad Aminuralif
Published: (2019)